Item 5. Other Information
Item 5. Other Information
During the quarter covered by this Quarterly Report on Form 10-Q, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
33
Item 6. Exhibits
EXHIBIT INDEX
Incorporated by Reference
Provided Herewith
Exhibit No. Description Form
File No.
Date of First Filing
Exhibit No.
3.1 Second Amended and Restated Certificate of Incorporation of MiniMed Group, Inc.
8-K
001-43183
March 9, 2026
3.1
3.2 Amended and Restated Bylaws of MiniMed Group, Inc.
8-K
001-43183 March 9, 2026
3.2
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
32.1 Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
32.2 Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
101.SCH Inline XBRL Schema Document. X
101.CAL Inline XBRL Calculation Linkbase Document. X
101.DEF Inline XBRL Definition Linkbase Document. X
101.LAB Inline XBRL Label Linkbase Document. X
101.PRE Inline XBRL Presentation Linkbase Document. X
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) X
34
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: September 8, 2026 MiniMed Group, Inc.
/s/ Chad Spooner
Name: Chad Spooner
Title: Executive Vice President, Chief Financial Officer
35
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.